197P Clinical benefit of HER2-targeted therapies versus prior chemotherapy in refractory HER2 expressing and mutant gastrointestinal malignancies
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2023 34 Supplement 2:S260-S260 - Subject
- Language
- ISSN
- 0923-7534